In a series of 101 melanoma lymph node metastases, using transcriptomic analyses on laser‐microdissected melanoma cells, we identified prominin‐2 (PROM2) as a biomarker predictive of distant metastases and decreased survival, thus providing a promising new bio‐target.4 This evidence concerns the gene PROM2 and melanoma.